Amitifadine: Completed Phase IIb/IIIa enrollment

Euthymics completed enrollment of 342 patients in the placebo-controlled, double-blind, U.S. Phase IIb/IIIa TRIADE trial comparing 50 and 100 mg amitifadine vs. Paxil paroxetine for 12 weeks in patie...